ab90543 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab90543 は 15 報の論文で使用されています。

  • Szymula A  et al. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome. PLoS Pathog 14:e1006890 (2018). PubMed: 29462212
  • Gion Y  et al. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci 108:1271-1280 (2017). IHC-P ; Human . PubMed: 28380678
  • Wille CK  et al. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency. J Virol 91:N/A (2017). PubMed: 28003489
  • Bilger A  et al. Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication. Oncotarget 8:44266-44280 (2017). PubMed: 28574826
  • Ferreiro JF  et al. EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features. Am J Transplant 16:414-25 (2016). IHC-P . PubMed: 26780579
  • Martin KA  et al. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1. J Virol 90:8520-30 (2016). PubMed: 27440880
  • Quan L  et al. PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro. PLoS One 10:e0136476 (2015). IHC-P ; Human . PubMed: 26361042
  • Accardi R  et al. The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental models. Carcinogenesis 36:1440-51 (2015). PubMed: 26424750
  • Bazot Q  et al. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2. PLoS Pathog 11:e1005031 (2015). PubMed: 26153983
  • Boreström C  et al. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions. J Gen Virol 93:1065-75 (2012). WB ; Human . PubMed: 22302879
  • Gibson SE  et al. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Am J Surg Pathol 35:807-15 (2011). PubMed: 21552113
  • Niedobitek G  et al. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 86:659-65 (1995). PubMed: 7605996
  • Rowe M  et al. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147-58 (1991). PubMed: 1845872
  • Young L  et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080-5 (1989). PubMed: 2552313
  • Young LS  et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69 ( Pt 5):1051-65 (1988). PubMed: 2836550